BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/27/2022 1:00:18 PM | Browse: 148 | Download: 374
 |
Received |
|
2022-06-20 14:31 |
|
Peer-Review Started |
|
2022-06-20 14:35 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-07-14 08:27 |
|
Revised |
|
2022-07-18 14:58 |
|
Second Decision |
|
2022-08-24 02:59 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-08-24 19:20 |
|
Articles in Press |
|
2022-08-24 19:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-09-14 12:46 |
|
Publish the Manuscript Online |
|
2022-09-27 13:00 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Case Report |
| Article Title |
Sudden extramedullary and extranodal Philadelphia-positive anaplastic large-cell lymphoma transformation during imatinib treatment for CML: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qiong Wu, Yong Kang, Jing Xu, Wen-Can Ye, Zhen-Jiang Li, Wen-Feng He, Yuan Song, Qing-Ming Wang, Ai-Ping Tang and Ting Zhou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Jiangxi “5511” Science and Technology Innovation Talent Project |
20171BCB18003 |
|
| Corresponding Author |
Zhen-Jiang Li, PhD, Chief Doctor, Department of Hematology, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang 330006, Jiangxi Province, China. lzjdgh@163.com |
| Key Words |
Chronic myeloid leukemia; BCR-ABL fusion gene; Imatinib mesylate; Anaplastic large-cell lymphoma; Philadelphia-positive; Nilotinib; Case report |
| Core Tip |
We describe a patient with chronic myeloid leukemia (CML) whose disease underwent a sudden transformation to anaplastic large-cell lymphoma (ALCL) following partial cytogenetic remission and early molecular response with 7 months of imatinib treatment. The patient developed a mass and felt pain in her left shoulders; a biopsy of the mass revealed ALCL, and BCR/ABL fusion was detected via fluorescence in situ hybridization. The patient was then treated with nilotinib and achieved complete cytogenetic remission and undetectable molecular residual disease within 6 mo. To the best of our knowledge, our patient is the first reported to have Philadelphia-positive ALCL transformed from CML. |
| Publish Date |
2022-09-27 13:00 |
| Citation |
Wu Q, Kang Y, Xu J, Ye WC, Li ZJ, He WF, Song Y, Wang QM, Tang AP, Zhou T. Sudden extramedullary and extranodal Philadelphia-positive anaplastic large-cell lymphoma transformation during imatinib treatment for CML: A case report. World J Clin Cases 2022; 10(28): 10339-10345 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i28/10339.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i28.10339 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
